GILEAD SCIENCES, INC. Operating Cash Flow 2007-2025 | GILD
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is GILEAD SCIENCES, INC.'s current operating cash flow?
GILEAD SCIENCES, INC. (GILD) annual operating cash flow for 2024 was $10.83B, a 35.25% increase from 2023. GILEAD SCIENCES, INC. operating cash flow for the quarter ending September 30, 2025 was $4.11B.
What was GILEAD SCIENCES, INC.'s operating cash flow in 2023?
GILEAD SCIENCES, INC. annual operating cash flow for 2023 was $8.01B, a 11.75% decline from 2022.
What was GILEAD SCIENCES, INC.'s operating cash flow in 2022?
GILEAD SCIENCES, INC. annual operating cash flow for 2022 was $9.07B, a 20.31% decline from 2021.
What is GILEAD SCIENCES, INC.'s 5-year operating cash flow CAGR?
GILEAD SCIENCES, INC. operating cash flow grew at a compound annual growth rate (CAGR) of 3.44% from FY2019 to FY2024, going from $9.14B to $10.83B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $10.83B | +35.2% | 10-K |
| FY2023 | $8.01B | -11.8% | 10-K |
| FY2022 | $9.07B | -20.3% | 10-K |
| FY2021 | $11.38B | +39.4% | 10-K |
| FY2020 | $8.17B | -10.7% | 10-K |
| FY2019 | $9.14B | +8.9% | 10-K |
| FY2018 | $8.40B | -29.4% | 10-K |
| FY2017 | $11.90B | -30.2% | 10-K |
| FY2016 | $17.05B | -19.8% | 10-K |
| FY2015 | $21.25B | +65.8% | 10-K |
| FY2014 | $12.82B | +312.8% | 10-K |
| FY2013 | $3.10B | -2.8% | 10-K |
| FY2012 | $3.19B | -12.2% | 10-K |
| FY2011 | $3.64B | +28.4% | 10-K |
| FY2010 | $2.83B | -8.0% | 10-K |
| FY2009 | $3.08B | +43.7% | 10-K |
| FY2008 | $2.14B | +28.4% | 10-K |
| FY2007 | $1.67B | - | 10-K |